Bluebird Health
Your China Medical Partner

Treatment effectiveness (surgery & critical)

90%

Average wait time reduced

95%

Overall cost vs Western countries

10%-15%

Our Services
OUR RESOURCES

Core Diagnosis & Doctor Resources

Direct links to 50+ flagship public Grade-A tertiary hospitals

Direct links to 50+ flagship public Grade-A tertiary hospitals across China, covering the international and VIP centers on the core Shanghai and Beijing campuses, with 2,000+ associate-chief or higher specialists able to take on complex and rare cases.

Direct links to 50+ flagship public Grade-A tertiary hospitals

Direct links to 50+ flagship public Grade-A tertiary hospitals across China, covering the international and VIP centers on the core Shanghai and Beijing campuses, with 2,000+ associate-chief or higher specialists able to take on complex and rare cases.

Direct links to 50+ flagship public Grade-A tertiary hospitals

Direct links to 50+ flagship public Grade-A tertiary hospitals across China, covering the international and VIP centers on the core Shanghai and Beijing campuses, with 2,000+ associate-chief or higher specialists able to take on complex and rare cases.

Direct links to 50+ flagship public Grade-A tertiary hospitals

Direct links to 50+ flagship public Grade-A tertiary hospitals across China, covering the international and VIP centers on the core Shanghai and Beijing campuses, with 2,000+ associate-chief or higher specialists able to take on complex and rare cases.

Direct links to 50+ flagship public Grade-A tertiary hospitals

Direct links to 50+ flagship public Grade-A tertiary hospitals across China, covering the international and VIP centers on the core Shanghai and Beijing campuses, with 2,000+ associate-chief or higher specialists able to take on complex and rare cases.

Direct links to 50+ flagship public Grade-A tertiary hospitals

Direct links to 50+ flagship public Grade-A tertiary hospitals across China, covering the international and VIP centers on the core Shanghai and Beijing campuses, with 2,000+ associate-chief or higher specialists able to take on complex and rare cases.

Direct links to 50+ flagship public Grade-A tertiary hospitals

Direct links to 50+ flagship public Grade-A tertiary hospitals across China, covering the international and VIP centers on the core Shanghai and Beijing campuses, with 2,000+ associate-chief or higher specialists able to take on complex and rare cases.

Direct links to 50+ flagship public Grade-A tertiary hospitals

Direct links to 50+ flagship public Grade-A tertiary hospitals across China, covering the international and VIP centers on the core Shanghai and Beijing campuses, with 2,000+ associate-chief or higher specialists able to take on complex and rare cases.

Direct links to 50+ flagship public Grade-A tertiary hospitals

Direct links to 50+ flagship public Grade-A tertiary hospitals across China, covering the international and VIP centers on the core Shanghai and Beijing campuses, with 2,000+ associate-chief or higher specialists able to take on complex and rare cases.

Direct links to 50+ flagship public Grade-A tertiary hospitals

Direct links to 50+ flagship public Grade-A tertiary hospitals across China, covering the international and VIP centers on the core Shanghai and Beijing campuses, with 2,000+ associate-chief or higher specialists able to take on complex and rare cases.

Direct links to 50+ flagship public Grade-A tertiary hospitals

Direct links to 50+ flagship public Grade-A tertiary hospitals across China, covering the international and VIP centers on the core Shanghai and Beijing campuses, with 2,000+ associate-chief or higher specialists able to take on complex and rare cases.

Direct links to 50+ flagship public Grade-A tertiary hospitals

Direct links to 50+ flagship public Grade-A tertiary hospitals across China, covering the international and VIP centers on the core Shanghai and Beijing campuses, with 2,000+ associate-chief or higher specialists able to take on complex and rare cases.

Direct links to 50+ flagship public Grade-A tertiary hospitals

Direct links to 50+ flagship public Grade-A tertiary hospitals across China, covering the international and VIP centers on the core Shanghai and Beijing campuses, with 2,000+ associate-chief or higher specialists able to take on complex and rare cases.

Direct links to 50+ flagship public Grade-A tertiary hospitals

Direct links to 50+ flagship public Grade-A tertiary hospitals across China, covering the international and VIP centers on the core Shanghai and Beijing campuses, with 2,000+ associate-chief or higher specialists able to take on complex and rare cases.

Direct links to 50+ flagship public Grade-A tertiary hospitals

Direct links to 50+ flagship public Grade-A tertiary hospitals across China, covering the international and VIP centers on the core Shanghai and Beijing campuses, with 2,000+ associate-chief or higher specialists able to take on complex and rare cases.

Direct links to 50+ flagship public Grade-A tertiary hospitals

Direct links to 50+ flagship public Grade-A tertiary hospitals across China, covering the international and VIP centers on the core Shanghai and Beijing campuses, with 2,000+ associate-chief or higher specialists able to take on complex and rare cases.

Direct links to 50+ flagship public Grade-A tertiary hospitals

Direct links to 50+ flagship public Grade-A tertiary hospitals across China, covering the international and VIP centers on the core Shanghai and Beijing campuses, with 2,000+ associate-chief or higher specialists able to take on complex and rare cases.

Direct links to 50+ flagship public Grade-A tertiary hospitals

Direct links to 50+ flagship public Grade-A tertiary hospitals across China, covering the international and VIP centers on the core Shanghai and Beijing campuses, with 2,000+ associate-chief or higher specialists able to take on complex and rare cases.

Direct links to 50+ flagship public Grade-A tertiary hospitals

Direct links to 50+ flagship public Grade-A tertiary hospitals across China, covering the international and VIP centers on the core Shanghai and Beijing campuses, with 2,000+ associate-chief or higher specialists able to take on complex and rare cases.

Direct links to 50+ flagship public Grade-A tertiary hospitals

Direct links to 50+ flagship public Grade-A tertiary hospitals across China, covering the international and VIP centers on the core Shanghai and Beijing campuses, with 2,000+ associate-chief or higher specialists able to take on complex and rare cases.

Direct links to 50+ flagship public Grade-A tertiary hospitals

Direct links to 50+ flagship public Grade-A tertiary hospitals across China, covering the international and VIP centers on the core Shanghai and Beijing campuses, with 2,000+ associate-chief or higher specialists able to take on complex and rare cases.

Direct links to 50+ flagship public Grade-A tertiary hospitals

Direct links to 50+ flagship public Grade-A tertiary hospitals across China, covering the international and VIP centers on the core Shanghai and Beijing campuses, with 2,000+ associate-chief or higher specialists able to take on complex and rare cases.

Direct links to 50+ flagship public Grade-A tertiary hospitals

Direct links to 50+ flagship public Grade-A tertiary hospitals across China, covering the international and VIP centers on the core Shanghai and Beijing campuses, with 2,000+ associate-chief or higher specialists able to take on complex and rare cases.

Direct links to 50+ flagship public Grade-A tertiary hospitals

Direct links to 50+ flagship public Grade-A tertiary hospitals across China, covering the international and VIP centers on the core Shanghai and Beijing campuses, with 2,000+ associate-chief or higher specialists able to take on complex and rare cases.

Zhilong Ai
Zhongshan Hospital, Fudan University

Clinical Expertise: Comprehensive treatment of thyroid, parathyroid, and cervical mass diseases within the field of general surgery.

Director of the Department of Thyroid and Breast Surgery at Zhongshan Hospital, Fudan University. National Committee Member of the Thyroid and Metabolic Surgery Group, Chinese Society of Surgery, Chinese Medical Association.

Tong Ji
Zhongshan Hospital, Fudan University

Clinical Expertise: Diagnosis and treatment of benign and malignant oral and maxillofacial tumors, as well as defect repair and reconstructive surgery.

Administrative Director of the Department of Oral and Maxillofacial Surgery. Vice Chair of the Oral and Maxillofacial Head and Neck Oncology Committee, Chinese Stomatological Association. China CMF Chair and Asia-Pacific Board Member of the AO Foundation / ASIF Cranio-Maxillofacial (CMF) Association.

Danfeng Xu
Shanghai Ruijin Hospital

Clinical Expertise: Organ-preserving surgical treatment of urological tumors.

Director of the Department of Urology at Ruijin Hospital, Shanghai Jiao Tong University School of Medicine. Committee Member of the Robotic Surgery Group, Chinese Urological Association.

Xianhong Shu
Zhongshan Hospital, Fudan University

Clinical Expertise: Diagnosis and treatment of cardiovascular diseases, with a specialization in echocardiographic imaging and cardiac ultrasound diagnostics.

Director of the Department of Echocardiography at Zhongshan Hospital, Fudan University.

Junmin Li
Shanghai Ruijin Hospital

Clinical Expertise: Diagnosis and treatment of hematologic malignancies, including leukemia, lymphoma, multiple myeloma, and immune-related hematologic disorders.

Director of the Department of Hematology at Ruijin Hospital, Shanghai Jiao Tong University School of Medicine.

Weili Zhao
Shanghai Ruijin Hospital

Clinical Expertise: Lymphoid malignancies, with a focus on the diagnosis and treatment of lymphocytic malignant diseases.

Vice President of Ruijin Hospital, Shanghai Jiao Tong University School of Medicine. Director of the Shanghai Key Clinical Medical Center. Executive Deputy Director of the Shanghai Institute of Hematology.

Xuefei Wang
Zhongshan Hospital, Fudan University

Clinical Expertise: Standardized surgical treatment of gastrointestinal tumors, minimally invasive laparoscopic surgery, and multidisciplinary team (MDT) management for advanced gastric cancer.

Deputy Director of the Department of General Surgery and Director of the Department of Gastrointestinal Surgery at Zhongshan Hospital, Fudan University. Committee Member of the Gastric Cancer Committee and Peritoneal Cancer Committee, Chinese Anti-Cancer Association.

Hui Cao
Renji Hospital, Shanghai Jiao Tong University School of Medicine

Clinical Expertise: Surgical and comprehensive treatment of gastric cancer, gastrointestinal stromal tumors (GIST), and colorectal cancer.

Chair of the Surgical Teaching and Research Office and Chief of General Surgery, Renji Clinical Medical College, Shanghai Jiao Tong University School of Medicine. Committee Member of the Gastrointestinal Surgery Group, Surgery Branch of the Chinese Medical Association.

Xiuying Xiao
Renji Hospital, Shanghai Jiao Tong University School of Medicine

Clinical Expertise: Diagnosis and treatment of malignant tumors, particularly gastrointestinal cancers, lung cancer, and neuroendocrine tumors.

Administrative Director of the Department of Oncology at Renji Hospital. Committee Member of the Gastric Cancer Committee of the Chinese Society of Clinical Oncology (Chinese Society of Clinical Oncology, CSCO).

Haiqiang Mai
Sun Yat‑sen University Cancer Center

Specializes in early diagnosis, individualized comprehensive treatment, treatment response prediction, and prognostic research of nasopharyngeal carcinoma.

Assistant President of the Hospital; Director of the Department of Nasopharyngeal Carcinoma, Sun Yat-sen University Cancer Center.

Guifang Guo
Sun Yat‑sen University Cancer Center

Specializes in comprehensive cancer treatment, with emphasis on systemic therapy for common malignancies including colorectal cancer, lung cancer, and breast cancer, particularly targeted therapy.

Member of the Targeted Therapy Committee, Chinese Anti-Cancer Association. Member of the Clinical Chemotherapy Committee, Chinese Anti-Cancer Association. Member of the Pancreatic Oncology Committee, Chinese Anti-Cancer Association.

Liangping Xia
Sun Yat‑sen University Cancer Center

Specializes in comprehensive cancer treatment, with focus on medical management of common cancers such as colorectal cancer, lung cancer, and breast cancer, particularly targeted therapy.

Director of the Department of Integrated Oncology, Sun Yat-sen University Cancer Center.

Yuehong Cui
Zhongshan Hospital, Fudan University

Clinical Expertise: Diagnosis and treatment of gastrointestinal malignancies, gastrointestinal stromal tumors (GIST), and neuroendocrine tumors, with extensive experience in targeted therapy and immunotherapy.

Committee Member and Secretary of the Gastrointestinal Oncology Group, Shanghai Medical Association Oncology Society. Committee Member of the Internal Medicine Group, 5th Gastric Cancer Committee, Chinese Anti-Cancer Association.

Jianmin Xu
Zhongshan Hospital, Fudan University

Surgical treatment of colorectal tumors, comprehensive management of colorectal cancer liver metastases, and minimally invasive surgery using the Da Vinci robotic system and laparoscopic techniques.

Director of the Department of Colorectal Surgery and Director of the Colorectal Cancer Center at Zhongshan Hospital, Fudan University.

Baiyong Shen
Shanghai Ruijin Hospital

Clinical Expertise: Radical surgical treatment of pancreatic cancer, pancreatic neuroendocrine tumors, pancreatic cystic lesions, and other complex pancreatic tumors.

Vice President of Ruijin Hospital, Shanghai Jiao Tong University School of Medicine. Deputy Director of the Shanghai Institute of Digestive Surgery. Director of the Institute of Pancreatic Diseases, Shanghai Jiao Tong University School of Medicine.

Yingbin Liu
Renji Hospital, Shanghai Jiao Tong University School of Medicine

Clinical Expertise: Clinical practice and research in hepatobiliary and pancreatic surgery, with expertise in standardized surgical resection and comprehensive treatment of gallbladder cancer, intrahepatic cholangiocarcinoma, hilar cholangiocarcinoma, and pancreatic cancer.

Director of the Cancer Center at Renji Hospital, Shanghai Jiao Tong University School of Medicine. Fellow of the American College of Surgeons (American College of Surgeons, FACS).

Xiong Ma
Renji Hospital, Shanghai Jiao Tong University School of Medicine

Clinical Expertise: Clinical diagnosis and immunological research in autoimmune liver diseases.

Director of the Department of Gastroenterology at Renji Hospital, Shanghai Jiao Tong University School of Medicine (concurrent). Deputy Director of the Shanghai Institute of Digestive Diseases (concurrent). Member of the International Autoimmune Hepatitis Group. Member of the Global Primary Biliary Cholangitis (PBC) Study Group.

Jie Hu
Shanghai Geriatric Medical Center

Clinical Expertise: Pulmonary nodule diagnosis and treatment, lung cancer screening and early detection, personalized targeted therapy and immunotherapy for lung cancer, interventional pulmonology, and comprehensive management of lung cancer comorbidities.

Deputy Director of the Department of Pulmonary and Critical Care Medicine at Shanghai Geriatric Medical Center. Fellow of the American College of Chest Physicians (FCCP). Vice Chair of the Small Cell Lung Cancer Committee, Chinese Society of Clinical Oncology (CSCO).

Yuanlin Song
Zhongshan Hospital, Fudan University

Clinical Expertise: Diagnosis and treatment of chronic obstructive pulmonary disease (COPD), bronchiectasis, pulmonary infections, and the management of acute and chronic respiratory failure.

Director of the Department of Pulmonary and Critical Care Medicine at Zhongshan Hospital, Fudan University.

Mingyuan Chen
Sun Yat‑sen University Cancer Center

Specializes in radiotherapy for early-stage nasopharyngeal carcinoma, minimally invasive surgical treatment of recurrent nasopharyngeal carcinoma, management of post-radiotherapy complications, and endoscopic skull base surgery.

Recipient of the “Clinical Medical Scientist” Program of Sun Yat-sen University Cancer Center. Reviewer for the National Natural Science Foundation of China (NSFC) preliminary review process.

Feng Yu
Beijing Jishuitan Hospital

Specializes in microwave and radiofrequency ablation for bone tumors, minimally invasive treatment of bone tumors, radiofrequency ablation of osteoid osteoma, routine diagnosis and treatment of bone and soft tissue tumors, limb-salvage surgery for bone tumors, and surgical and palliative treatment of bone metastases.

Vice President, Beijing Jishuitan Hospital; Chief Physician, Department of Orthopedic Oncology.

Jianming Guo
Zhongshan Hospital, Fudan University

Clinical Expertise: Diagnosis and treatment of renal cancer, prostate cancer, bladder cancer, adrenal tumors, and complex urinary tract stones.

Director of the Department of Urology at Zhongshan Hospital, Fudan University. Standing Committee Member and Deputy Secretary-General of the World Chinese Urological Association. Led a team with a cumulative experience of over 7,000 robotic-assisted surgeries.

Da He
Beijing Jishuitan Hospital

Specializes in spinal trauma, degenerative diseases, and spinal deformities, with expertise in minimally invasive spine surgery, spinal correction techniques, spinal navigation, and non-fusion procedures such as artificial disc replacement. Director of Spine Surgery, Beijing Jishuitan Hospital.

Has over 28 years of clinical experience in spine surgery. Performed more than 250 robot-assisted thoracolumbar spinal surgeries and over 50 robot-assisted cervical spinal surgeries.

Qiang Gao
Zhongshan Hospital, Fudan University

Clinical Expertise: Complex hepatobiliary surgeries and minimally invasive procedures for challenging liver and biliary diseases.

Director of the Department of Liver Surgery and Liver Transplantation at Zhongshan Hospital, Fudan University. Performs approximately 500 hepatobiliary tumor and liver transplantation surgeries annually as lead surgeon.

Shugen Gao
Cancer Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College

Specializes in minimally invasive surgery for lung cancer.

Vice Director, National Cancer Center; Vice President, Cancer Hospital, Chinese Academy of Medical Sciences.

Yuankai Shi
Cancer Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College

Specializes in lymphoma, lung cancer chemotherapy, and targeted therapy.

Vice President, Cancer Hospital, Chinese Academy of Medical Sciences.

Hong Hu
Fudan University Shanghai Cancer Center

Specializes in minimally invasive and multidisciplinary treatment of thoracic tumors including lung cancer, esophageal cancer, and mediastinal tumors, with particular expertise in thoracic minimally invasive surgery.

Director, Department of Thoracic Surgery, Fudan University Shanghai Cancer Center. Executive Deputy Director, Institute of Thoracic Oncology, Fudan University Shanghai Cancer Center.

Xinxiang Li
Fudan University Shanghai Cancer Center

Clinical Expertise: Comprehensive surgical-based precision treatment of colon cancer, rectal cancer, and other colorectal malignancies.

Director of the Department of Colorectal Surgery at Fudan University Shanghai Cancer Center. Has performed more than 10,000 colorectal surgical procedures cumulatively.

Houbao Liu
Zhongshan Hospital, Fudan University

Clinical Expertise: Precision treatment of biliary malignancies, including gallbladder cancer, bile duct cancer, and ampullary tumors; minimally invasive treatment of biliary stones and congenital bile duct dilatation; and surgical management of complex biliary diseases and bile duct injuries.

Director of the Fudan University Institute of Biliary Disease. Director of the Department of Biliary Surgery and Director of the Biliary Disease Center at Zhongshan Hospital, Fudan University. Committee Member of the International Association of Surgeons, Gastroenterologists and Oncologists (IASGO). Committee Member of the China Chapter of the International Hepato-Pancreato-Biliary Association (IHPBA).

Liang Liu
Zhongshan Hospital, Fudan University

Clinical Expertise: Clinical and translational research in pancreatic tumors and pancreatic surgery.

Director of the Department of Pancreatic Surgery at Zhongshan Hospital, Fudan University.

Yuhong Zhou
Zhongshan Hospital, Fudan University

Clinical Expertise: Soft tissue sarcomas, malignant bone tumors, pancreatic malignancies, neuroendocrine tumors, as well as targeted therapy and immunotherapy for solid tumors.

Committee Member and Secretary of the Gastrointestinal Oncology Group, Shanghai Medical Association Oncology Society. Committee Member of the Internal Medicine Group, 5th Gastric Cancer Committee, Chinese Anti-Cancer Association.

Tianshu Liu
Zhongshan Hospital, Fudan University

Clinical Expertise: Gastrointestinal malignancies and rare tumors, including gastrointestinal stromal tumors (GIST), neuroendocrine tumors, as well as targeted therapy and immunotherapy for solid tumors.

Director of the Department of Medical Oncology at Zhongshan Hospital, Fudan University.

Weiqi Lu
Zhongshan Hospital, Fudan University

Clinical Expertise: Multidisciplinary and individualized treatment of abdominal and retroperitoneal soft tissue tumors, peritoneal malignancies, and other complex tumor conditions, with surgery as the primary treatment approach.

Founder of the Department of Retroperitoneal and Soft Tissue Tumor Surgery at Zhongshan Hospital, Fudan University. Performs approximately 700 retroperitoneal tumor surgeries annually.

Dr. Sun Huichuan
Zhongshan Hospital, Fudan University

Hepatobiliary Tumor & Liver Transplant Surgery

Deputy director of the Hepatobiliary Tumor & Liver Transplant Surgery dept., Zhongshan Hospital, Fudan University; clinical focus on high-difficulty liver surgery and complex perioperative management, with nearly 30 years of front-line clinical work.

Jiabin Jin
Shanghai Ruijin Hospital

Clinical Expertise: Clinical diagnosis and treatment of pancreatic tumors, robotic minimally invasive surgery, and multidisciplinary management of complex pancreatic diseases.

Medical Vice President and Chief of General Surgery, Ruijin Hospital Hainan Hospital, Shanghai Jiao Tong University School of Medicine. Visiting physician at the Hepatobiliary Center, Paul Brousse Hospital, France.

Zhimin Shao
Fudan University Shanghai Cancer Center

Clinical Expertise: Clinical treatment and translational research in breast cancer.

Director of the Breast Cancer Center at Fudan University Shanghai Cancer Center. Director of the Cancer Institute of Fudan University. Director of the Breast Cancer Research Institute of Fudan University.

Hongxia Wang
Fudan University Shanghai Cancer Center

Clinical Expertise: Precision diagnosis and translational research in recurrent and metastatic breast cancer and pancreatic cancer.

Director of the Department of Medical Oncology at Fudan University Shanghai Cancer Center.

Tao
West China Hospital, Sichuan University

Specializes in knee and hip arthroplasty, revision surgery for prosthetic infection after knee and hip replacement, and spinal disorders.

Chairman of the Academic Committee, Orthopedic Medicine Department, Chinese PLA General Hospital Fourth Medical Center.

刘斌
West China Hospital, Sichuan University

心血管外科手术的临床麻醉及困难气道管理

四川大学华西医院 麻醉中心副主任

Mengtao Li
Peking Union Medical College Hospital

Specializes in systemic lupus erythematosus, Sjögren’s syndrome, rheumatoid arthritis, spondyloarthritis, systemic vasculitis, systemic sclerosis (scleroderma), dermatomyositis, and connective tissue disease–associated pulmonary hypertension, as well as other rheumatic and immunological disorders.

Tenured Professor (PUMC Scholar), Director of the Department of Rheumatology and Immunology, Peking Union Medical College Hospital. Member of the Asia Pacific League of Associations for Rheumatology (APLAR) Systemic Lupus Erythematosus Research Group. Member of the Asia-Pacific Lupus Collaboration (APLC).

孙凌云
Affiliated Drum Tower Hospital, Medical School of Nanjing University

间充质干细胞治疗自身免疫病

南京大学风湿免疫研究所所长

Shengli Li
The Ninth People’s Hospital, Shanghai Jiao Tong University School of Medicine

Specializes in rhinoplasty, crooked nose correction, blepharoplasty, and microsurgical lymphatic reconstruction.

Member of the International Confederation for Plastic, Reconstructive and Aesthetic Surgery (IPRAS). Member of the International Society of Lymphology (ISL). Member of the Italian Society of Microsurgery (ISM).

Xiaoxi Lin
The Ninth People’s Hospital, Shanghai Jiao Tong University School of Medicine

Specializes in facial aesthetic surgery and rejuvenation, vascular malformations, hemangiomas, and birthmarks.

Deputy Director of Plastic and Reconstructive Surgery, Shanghai Ninth People's Hospital. Standing Committee Member of the Medical Aesthetics Branch of the Chinese Medical Association; Head of the Aesthetic Surgery Group.

Qingfeng Li
The Ninth People’s Hospital, Shanghai Jiao Tong University School of Medicine

Specializes in head and facial trauma, facial plastic and reconstructive surgery, facial rejuvenation treatments, and management of cutaneous tumors.

Vice President, Shanghai Ninth People's Hospital; Director of Plastic and Reconstructive Surgery, Shanghai Ninth People's Hospital. Fellow of the American Association of Plastic Surgeons (AAPS, est. 1921); Editorial Board Member. Founding Member of the American Society for Reconstructive Transplantation (ASRT).

Jinhua Xu
Huashan Hospital, Fudan University

Clinical Expertise: Diagnosis and treatment of allergic skin diseases such as urticaria, eczema, and atopic dermatitis; sexually transmitted diseases including condyloma acuminatum, syphilis, and genital herpes; as well as vitiligo, acne, melasma, psoriasis, systemic lupus erythematosus, and other complex dermatological conditions.

Director of the Department of Dermatology at Huashan Hospital, Fudan University. Chair of the Department of Dermatology and Venereology, Shanghai Medical College of Fudan University.

Qinping Yang
Huashan Hospital, Fudan University

Clinical Expertise: Diagnosis and treatment of hair loss, acne, vitiligo, psoriasis, melasma, eczema, and ichthyosis, with experience in integrated traditional Chinese and Western medicine approaches for common dermatological diseases.

Deputy Director of the Department of Dermatology at Huashan Hospital, Fudan University.

Teng Mao
Shanghai Chest Hospital

Specializes in minimally invasive surgical treatment of benign and malignant diseases of the lung, esophagus, mediastinum, and trachea, as well as surgical management after induction therapy for locally advanced lung cancer (T3/N2), esophageal cancer, and malignant mediastinal tumors, with expertise in multidisciplinary comprehensive treatment.

Deputy Director of Thoracic Surgery, Shanghai Chest Hospital; Deputy Head of the Mediastinal Subspecialty Group. Has performed over 5,000 thoracic surgical procedures as primary surgeon.

Zhigang Li
Shanghai Chest Hospital

Specializes in robot-assisted minimally invasive thoracic surgery.

Director of Thoracic Surgery, Shanghai Chest Hospital. Executive Committee Member, International Society for Diseases of the Esophagus (ISDE). Member of the American Association for Thoracic Surgery (AATS). Member of the European Society of Thoracic Surgeons (ESTS).

Haiquan Chen
Fudan University Shanghai Cancer Center

Thoracic surgeon and pioneer in individualized surgical treatment for early-stage lung cancer.

Director, Institute of Thoracic Oncology, Fudan University Shanghai Cancer Center. Chief Expert of Thoracic Tumor MDT, Director of Lung Cancer Prevention and Treatment Center. Fellow of the Royal College of Surgeons (RCS), UK. Member of the European Society of Thoracic Surgeons (ESTS).

Kaiyan Liu
Peking University People’s Hospital

Specializes in diagnosis and treatment of hematologic diseases and hematopoietic stem cell transplantation.

Deputy Director of Peking University Institute of Hematology.

Xiaojun Huang
Peking University People’s Hospital

Specializes in cutting-edge research and clinical treatment of leukemia and other malignant hematologic diseases. Director of Hematology Department, Peking University People's Hospital; Director of Peking University Institute of Hematology; Director of National Clinical Research Center for Hematologic Diseases.

Chairman of the Standing Committee of the Asia-Pacific Blood Association. Vice President of the 4th Council of the World Chinese Doctors Association.

Juan Du
Renji Hospital, Shanghai Jiao Tong University School of Medicine

Clinical Expertise: Complex and refractory hematologic disorders, with a focus on plasma cell diseases, lymphoma, leukemia, and hematopoietic stem cell transplantation.

Director of the Department of Hematology at Renji Hospital, Shanghai Jiao Tong University School of Medicine. Member of the International Myeloma Working Group (IMWG) Expert Committee, and Member of the IMWG Cellular Immunotherapy Committee.

Shanlin Chen
Beijing Jishuitan Hospital

Specializes in wrist injuries, peripheral nerve injuries, congenital hand deformities, and microsurgical reconstruction and repair.

Vice President, Beijing Jishuitan Hospital; Director of Hand Surgery. Vice President of the Asia-Pacific Wrist Association (APWA). Member of the Hand Surgery Committee, International Society of Orthopaedic Surgery and Traumatology (SICOT).

张华勇
Affiliated Drum Tower Hospital, Medical School of Nanjing University

类风湿关节炎、强直性脊柱炎、系统性红斑狼疮、肌炎/皮肌炎、白塞病、痛风等疾病的诊治以及干细胞治疗自身免疫性疾病

科室行政副主任

Xinyang Hu
The Second Affiliated Hospital, Zhejiang University School of Medicine

Specializes in radiotherapy for early-stage nasopharyngeal carcinoma, minimally invasive surgical treatment of recurrent nasopharyngeal carcinoma, management of post-radiotherapy complications, and endoscopic skull base surgery.

Recipient of the “Clinical Medical Scientist” Program of Sun Yat-sen University Cancer Center. Reviewer for the National Natural Science Foundation of China (NSFC) preliminary review process.

Deke Fei Dou
Fuwai Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College中国医学科...

Specializes in clinical diagnosis, interventional treatment, and related basic research in coronary heart disease.

Director of Internal Medicine Management Committee, Fuwai Hospital, Chinese Academy of Medical Sciences. Director of Cardiometabolic Center; Deputy Director of Coronary Artery Disease Center, Fuwai Hospital. Vice Chairman of the Interventional Cardiology Committee, Asian Heart Society (AHS).

Chang Shu
Fuwai Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College中国医学科...

Specializes in minimally invasive endovascular and surgical treatment of aortic diseases, as well as surgical and interventional management of peripheral vascular diseases, cervical vascular diseases, and visceral vascular diseases.

Director of the Vascular Surgery Center and Director of Vascular Center Ward 2, Fuwai Hospital, Chinese Academy of Medical Sciences. Former Vice President of the International Society for Vascular Surgery.

Xiangbin Pan
Fuwai Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College中国医学科...

Specializes in interventional and surgical treatment of congenital heart disease and valvular heart disease.

Vice President, National Center for Cardiovascular Diseases; Vice President, Fuwai Hospital, Chinese Academy of Medical Sciences. International Senior Fellow of the European Society of Cardiology (ESC). International Senior Fellow of the American College of Cardiology (ACC). International Senior Fellow of the Society for Cardiovascular Angiography and Interventions (SCAI). International Senior Fellow of the Society of Thoracic Surgeons (STS).

Xingquan Zhao
Beijing Tiantan Hospital, Capital Medical University

Specializes in the diagnosis and treatment of cerebrovascular diseases.

Director of Neurology Center and Director of Department of Vascular Neurology, Beijing Tiantan Hospital.

Junbo Ge
Zhongshan Hospital, Fudan University

Clinical Expertise: Diagnosis and treatment of cardiovascular diseases.

Director of the Department of Cardiology at Zhongshan Hospital, Fudan University. One of the six Executive Board Members of the World Heart Federation.

Jianguo Wei
Zhongshan Hospital, Fudan University

Clinical Expertise: Diagnosis and treatment of various vascular diseases.

Director of the Institute of Vascular Surgery, Fudan University. Deputy Director of the National Clinical Research Center for Radiology and Therapy.

Dr. Zhang Mingyuan
Beijing United Family Hospital

Dr. Zhang Mingyuan

Dr. Zhang Mingyuan — 28 years of clinical experience.

Chunyan Jiang
Beijing Jishuitan Hospital

Specializes in shoulder trauma and sports injuries, including fractures and dislocations of the proximal humerus and shoulder girdle, as well as shoulder arthroplasty.

Member of the Party Committee and Executive Vice President of Beijing Jishuitan Hospital.

Wei Zhang
Shanghai Sixth People’s Hospital, Shanghai Jiao Tong University School of Medicine

Specializes in orthopedic trauma management; treatment of fracture complications such as nonunion, deformity, osteonecrosis, and functional impairment; revision surgery for failed fracture treatment; joint arthroplasty; and robot-assisted minimally invasive fracture surgery.

Deputy Administrative Director of Orthopedics, National Orthopedic Medical Center, Shanghai Sixth People's Hospital. Member of the Trauma Committee, Chinese Branch of the International Society of Orthopaedic Surgery and Traumatology.

Congfeng Luo
Shanghai Sixth People’s Hospital, Shanghai Jiao Tong University School of Medicine

Specializes in the treatment and revision of complex tibial plateau fractures, peri-knee osteotomy for deformity correction, management of peri-knee fractures with ligament and soft tissue injuries, and emergency care for complex pelvic fractures.

Davos AO Master Course Director, Department of Orthopedic Trauma, Shanghai Sixth People's Hospital. Associate Director, Orthopedic Trauma Institute, Shanghai Jiao Tong University. International Instructor, Davos AO Master Course.

Shen Liu
Shanghai Sixth People’s Hospital, Shanghai Jiao Tong University School of Medicine

Specializes in fractures and dislocations of the extremities, hand trauma, tendon injury with adhesion and functional reconstruction, elbow and knee stiffness, as well as soft tissue defect reconstruction and repair.

Director, Department of Hand and Reconstructive Surgery, Shanghai Sixth People's Hospital.

Cunyi Fan
Shanghai Sixth People’s Hospital, Shanghai Jiao Tong University School of Medicine

Specializes in the diagnosis and treatment of fractures of the extremities, complex limb dysfunction and deformities, bone and soft tissue infections and defects, nonunion, and peripheral nerve injuries.

Administrative Director of Orthopedics, Shanghai Sixth People's Hospital.

OUR RESOURCES

Patient Stories

FAQ

Common Questions

001
Why is professional cross-border care planning necessary?
Every step of major-disease treatment is critical — each choice directly affects cure rates and recovery quality. Modern clinical medicine has an extremely high threshold; ordinary patients cannot judge the quality or suitability of treatment plans. There is a natural information barrier between doctors and patients, and cognitive gaps can easily lead to misdiagnosis and delayed treatment. Medical standards vary significantly across countries, and the ceiling of available medical resources determines the ceiling of outcomes.
002
What are "international medical services in China"?
International medical services in China refer to overseas patients traveling to China for diagnosis, surgery, health check-ups, or second medical opinions, with full-process support from international medical centers — including appointment booking, translation, care coordination, and follow-up management. Many Grade-A tertiary hospitals and international hospitals in China have established international patient centers offering multilingual support and standardized medical service systems.
003
Why seek medical treatment in China?
China offers world-leading clinical experience and techniques in oncology, cardiology, neurosurgery, and more. Major tertiary hospitals handle large case volumes with complete expert teams, while treatment costs remain more favorable than in Europe or the US. Combined with unique traditional Chinese medicine resources and an improving international medical service system, overseas patients can access high-quality care at a reasonable cost.
004
Which hospitals can receive international patients?
We partner with the international medical departments of leading tertiary hospitals in Beijing, Shanghai, Guangzhou, and other cities, as well as renowned international hospitals — all licensed for international medical services with multilingual capabilities. We match you with the right hospital and expert team based on your condition and needs.
NEWS

News & Insights

Bluebird carries wellness across mountains and seas:
how a "flying bird" brings China's quality care within global patients' reach
More News
Xinhua Viewpoint | Why Are Foreign Patients Flocking to China for Medical Treatment?
Xinhua Viewpoint | Why Are Foreign Patients Flocking to China for Medical Treatment?
A foreign blogger suffering from severe stomach pain traveled all the way to China for medical treatment after becoming frustrated with the inefficiency of healthcare services in his home country. Recently, similar videos have gone viral on social media, sparking widespread discussion about the growing number of foreigners coming to China for medical care.
People’s Daily Health Client: Efficient and Cost-Effective — More and More Foreign Patients Are Coming to China for Medical Treatment
People’s Daily Health Client: Efficient and Cost-Effective — More and More Foreign Patients Are Coming to China for Medical Treatment
“I was able to have my surgery and be discharged within just one week in China. That’s faster than getting treatment for a common cold back home!” Before coming to the First Affiliated Hospital of Zhejiang University School of Medicine, Saleh (pseudonym) from Bangladesh had sought medical care in several countries but was still unable to determine the cause of his illness.
High-Quality Care at Competitive Prices | Chinese Hospitals Are Winning Over Foreign Patients
High-Quality Care at Competitive Prices | Chinese Hospitals Are Winning Over Foreign Patients
According to statistics, the number of international patients treated annually at China’s major hospitals serving foreign patients has increased by 73.6% over the past three years, highlighting the growing appeal of China’s healthcare services among international patients.

The bluebird symbolizes hope and trust

Consult Now